Stem Cells May Lower Infection Risk in Transplant Recipients

Share this content:

The use of mesenchymal stem cells derived from bone marrow instead of antibody induction may result in a lower incidence of acute rejection in adults receiving related-donor kidney transplants. John Schieszer reports in today's Medical Minute that these autologous stem cells may help decrease opportunistic infections in this patient population.
You must be a registered member of Renal and Urology News to post a comment.

Sign Up for Free e-newsletters